The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cozzo, C.
Right arrow Articles by Caton, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cozzo, C.
Right arrow Articles by Caton, A. J.
The Journal of Immunology, 2003, 171: 5678-5682.
Copyright © 2003 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Self-Peptides Drive the Peripheral Expansion of CD4+CD25+ Regulatory T Cells 1

Cristina Cozzo, Joseph Larkin, III and Andrew J. Caton2

The Wistar Institute, Philadelphia, PA 19104


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
CD4+CD25+ regulatory T cell selection is initiated by high-specificity interactions with self-peptides in the thymus, although how these cells respond to cytokine-derived signals and to re-exposure to self-peptide:MHC complexes in the periphery is not well understood. We have used a transgenic mouse system, in which the peptide that induces thymic selection of a clonal population of CD4+CD25+ regulatory T cells is known, to show that CD4+CD25+ T cells proliferate in response to their selecting self-peptide in vivo. Moreover, they do not proliferate in response to lymphopenia in the absence of the selecting self-peptide, reflecting a low level of expression of the high affinity receptor for IL-7 (CD127) relative to conventional CD4+ T cells. That their selecting self-peptide is both required for and promotes the peripheral expansion of CD4+CD25+ regulatory T cells may direct their accumulation in sites where the self-peptide is expressed.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
The naive CD4+ T cell repertoire is primarily defined by selection events occurring in the thymus, but is also shaped by peripheral homeostatic mechanisms, such as interactions with self-peptide:MHC complexes and cytokine-derived signals, which influence the survival and lymphopenia-induced expansion of CD4+ T cells. In the absence of stimulation by self-peptide:MHC complexes, naive CD4+ T cells do not undergo lymphopenia-induced proliferation and die rapidly (1). Naive T cells may require peripheral expression of the self-peptides that mediated their positive selection in the thymus to promote homeostatic proliferation (2, 3, 4). In addition, cytokines play a key role in the maintenance of naive T cells (1). For conventional CD4+ T cells, signals received through the IL-7R{alpha} chain (CD127) paired with the common {gamma}-chain have been shown to promote proliferation in response to low-affinity interactions with self-peptide:MHC complexes, particularly under conditions of lymphopenia (5, 6).

However, 5–10% of the peripheral CD4+ T cells in normal mice are CD25+CD45RBlow cells that have been shown to have regulatory function (7). CD4+CD25+ regulatory T cells are generated as a result of high-affinity interactions with cognate self-peptide:MHC complexes in the thymus (8, 9). Although there is evidence that the sustained presence of CD4+ regulatory T cells may depend on the peripheral expression of self-Ag (10), how interactions with self-peptide:MHC complexes in the periphery contribute to maintaining or expanding the repertoire of CD4+CD25+ regulatory T cells has only begun to be examined (11, 12, 13). In this report, we have examined how CD4+CD25+ regulatory T cells respond to stimuli that could promote their expansion in the periphery using TS1 x HA28 mice. In TS1 x HA28 mice, thymocytes expressing the clonotypic 6.5 TCR undergo selection to become CD4+CD25+ regulatory T cells through interactions with the S1 peptide from influenza virus hemagglutinin expressed as a neo-self-peptide (8, 14). We show that 6.5highCD4+CD25+ regulatory T cells proliferate in response to S1 peptide in the periphery of HA28 mice. However, unlike conventional CD4+ T cells, CD4+CD25+ cells do not proliferate in response to lymphopenia in BALB/c mice (that lack S1 peptide). Their differing responsiveness to TCR vs lymphopenia-induced signals likely shapes the accumulation and activity of CD4+CD25+ regulatory T cells at sites where their selecting self-peptides are expressed.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Mice

TS1, TS1 x HA28, HA28, and TS1(SW) mice have been previously described (8, 14, 15). Recipient BALB/c (Harlan, Indianapolis, IN) and HA28 mice for adoptive transfers were left either nonmanipulated or were sublethally irradiated with 500 rad of gamma irradiation. All mice were maintained in sterile microisolators at The Wistar Institute animal facility and were used between 10 and 28 wk of age.

Flow cytometry

Single-cell suspensions of cells pooled from axillary, inguinal, brachial, and superficial cervical lymph nodes (LN)3 were stained with the following mAbs for flow-cytometric analysis: purified anti-CD16/32 (Fc block; 2.4G2; BD PharMingen, San Diego, CA), anti-CD4-allophycocyanin or anti-CD4-FITC (L3T4; BD PharMingen), anti-CD25-PE (PC61; BD PharMingen), anti-CD25-biotin or anti-CD25-FITC (7D4; BD PharMingen), anti-V{alpha}8.3-biotin (KT50; BD PharMingen), anti-CD127-PE (SB/14; BD PharMingen; or A7R34; eBioscience, San Diego, CA), and 6.5-biotin (15). Streptavidin-Red670 (Invitrogen, Carlsbad, CA) was used to detect biotinylated reagents. Three- or four-color analyses were performed on either FACScan or FACSCalibur flow cytometers, respectively (BD Biosciences, San Jose, CA). Data analysis of 100,000–400,000 live events was performed using FlowJo software (Tree Star, San Carlos, CA). Cell populations were purified by FACS from pooled axillary, inguinal, brachial, and superficial cervical LN to ~95% purity at The Wistar Institute’s sorting facility using a Cytomation MoFlo and Summit software (Cytomation, Fort Collins, CO).

CFSE labeling

Purified CD4+CD25+ and CD4+CD25- T cells from TS1 x HA28 LN were labeled in vitro with the fluorescent dye CFSE (Molecular Probes, Eugene, OR) as previously described (16). Briefly, purified CD4+CD25+ or CD4+CD25- T cells or unfractionated TS1(SW) LN cells were washed into serum-free IMDM, incubated with 5 mM CFSE at 1 x 107 cells/ml for 4 min, and then incubated with 50% serum. Labeled cells were then washed into serum-free medium for adoptive transfers.

Adoptive transfers

A total of 1.5–2 x 106 purified CFSE-labeled CD4+CD25+ or CD4+CD25- cells were injected into the tail veins of recipient mice. In some cases, 3 x 106 CFSE-labeled TS1(SW) LN cells were coinjected with the CFSE-labeled CD4+CD25+ or CD4+CD25- T cells. Seven days later, axillary, brachial, inguinal, and superficial cervical LN were harvested from recipient mice and stained for flow cytometry. In some experiments, CFSE-labeled CD4+CD25+ cells were purified by FACS from the LN and spleens of recipient mice and used for in vitro assays.

In vitro proliferation assays

Proliferation assays were performed as previously described (14). Briefly, CFSE-labeled CD4+CD25+ or CD4+CD25- cells from TS1 x HA28 mice were cultured with irradiated BALB/c splenocytes and stimulated with 1 µM S1 peptide in presence or absence of 10 ng/ml IL-2. Four days later, cells were stained for flow cytometry. For suppressor function analysis, 1 x 106 responder TS1 LN cells were cultured with graded numbers of purified cells from TS1 x HA28 mice or from adoptive transfer recipient mice. Cells were stimulated with 0.3 µM S1 peptide in the presence of irradiated BALB/c splenocytes (5 x 106) for 72 h, and then pulsed with 0.5 µCi/well [3H]thymidine and harvested 16 h later.


    Results and Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
CD4+CD25+ regulatory T cells express low levels of CD127

TS1 mice express a transgenic TCR specific for the S1 peptide of hemagglutinin that can be detected with the mAb 6.5 (15). We previously showed that interactions with S1 peptide induce 6.5highCD4 single-positive thymocytes to undergo CD25+ regulatory T cell selection in TS1 x HA28 mice, which express S1 in both the thymus and periphery (8, 14). 6.5highCD4+CD25+ regulatory T cells coexist in equal ratios and with equal numbers of 6.5highCD4+CD25- T cells in TS1 x HA28 mice (Fig. 1A; Ref.8). Because signals received from cytokines and self-peptide:MHC complexes can each contribute to the maintenance of conventional CD4+ T cells (1, 4), we were interested in determining how 6.5highCD4+CD25+ regulatory T cells respond to these signals in the periphery. 6.5highCD4+CD25+ T cells from TS1 x HA28 mice expressed lower levels of CD127, the high-affinity receptor for IL-7, than 6.5highCD4+CD25- T cells (Fig. 1B). CD4+CD25+ T cells from BALB/c mice showed similarly reduced levels of CD127 in comparison with CD4+CD25- T cells, excluding the possibility that the low levels of CD127 expression among 6.5highCD4+CD25+ T cells in TS1 x HA28 mice relates to the expression of a transgene-encoded TCR (Fig. 1C). These data are consistent with other studies (12, 17) and suggested that CD4+CD25+ and CD4+CD25- cells could differ in their abilities to respond to lymphopenia, where IL-7 is critical for the homeostatic proliferation of conventional CD4+ T cells (5).



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 1. CD4+CD25+ T cells from TS1 x HA28 and BALB/c mice express lower levels of CD127 than CD4+CD25- T cells. Axillary, inguinal, brachial, and superficial cervical LN from TS1, TS1 x HA28, or BALB/c mice were pooled and stained for surface expression of CD4, 6.5, CD25, and CD127 or an isotype control for flow cytometry. A, CD25 expression on 6.5highCD4+ T cells from TS1 or TS1 x HA28 LN cells. Histograms gated on CD4+ lymphocytes. Bars indicate 6.5high (left panels) or CD25+ (right panels) cells, and the frequency for each population is shown. B, Expression of CD127 on 6.5highCD4+CD25+ (thin line), 6.5highCD4+CD25- (thick line), or 6.5highCD4+ lymphocytes stained with an isotype control Ab (filled histogram) from TS1 x HA28 mice. C, Expression of CD127 on CD4+CD25+ (thin line), CD4+CD25- (thick line), or CD4+ lymphocytes stained with an isotype control Ab (filled histogram) from BALB/c mice. Mean fluorescence intensities for CD4+CD25+ vs CD4+CD25- populations from TS1 x HA28 and BALB/c mice are shown.

 
6.5highCD4+CD25+ T cells do not proliferate in response to lymphopenia alone

To directly examine their abilities to respond to lymphopenia, CD4+CD25+ and CD4+CD25- T cells were purified from LN of TS1 x HA28 mice by cell sorting, labeled with the intracellular dye CFSE, and injected into normal or sublethally irradiated BALB/c mice. We also coinjected a second population of CFSE-labeled LN cells from TS1(SW) mice, which express a TCR specific for an analog of the S1 determinant (termed S1(SW); Ref.8). Seven days later, LN cells were harvested from recipient mice and stained with 6.5 to identify cells from TS1 x HA28 mice or with anti-V{alpha}8.3 to identify cells from TS1(SW) mice (8), and the division of the transferred cells was determined based on decreasing CFSE intensity. As expected (2, 4), none of the transferred cell populations divided in nonirradiated BALB/c mice (Fig. 2A). When transferred into lymphopenic BALB/c mice, both the 6.5highCD4+CD25- T cells from TS1 x HA28 mice (which express CD127) and the CD4+V{alpha}8+ T cells from TS1(SW) mice underwent one to two rounds of division. However, the 6.5highCD4+CD25+ T cells from TS1 x HA28 mice failed to proliferate in lymphopenic BALB/c mice. The recipient mice were indeed lymphopenic, because the CD4+V{alpha}8+ cells that were cotransferred with the 6.5highCD4+CD25+ T cells went through one to two rounds of homeostatic division. Therefore, 6.5highCD4+CD25+ T cells, which express low levels of CD127, do not appear to respond to signals derived from IL-7 or to any other stimuli presented by lymphopenic environments lacking S1 peptide.



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 2. 6.5highCD4+CD25+ T cells require the presence of S1 peptide to proliferate. A, A total of 1.5–2 x 106 CFSE-labeled CD4+CD25+ or CD4+CD25- cells from TS1 x HA28 mice were mixed with ~3 x 106 CFSE-labeled LN cells from TS1(SW) mice and injected i.v. into normal or sublethally irradiated BALB/c (left panels) or HA28 (right panels) mice. Seven days later, LN from recipient mice were harvested, stained, and analyzed by flow cytometry. Histograms are gated on CD4+6.5highCFSE+ cells or CD4+V{alpha}8+CFSE+ cells. Cell populations were labeled with CFSE separately, causing differences in the fluorescence intensity of undivided CFSE-labeled cells. Data are representative of four experiments. B, Purified CD4+CD25+ and CD4+CD25- T cells from TS1 x HA28 mice were stimulated in vitro with 1 µM S1 peptide in the presence or absence of exogenous IL-2. Four days later, cells were stained for flow cytometry to assess for proliferation by decreasing CFSE intensity. Histograms are gated on 6.5highCD4+ cells and are representative of three experiments.

 
S1 peptide drives the peripheral expansion of 6.5highCD4+CD25+ T cells

We next transferred CFSE-labeled CD4+CD25+ or CD4+CD25- cells from TS1 x HA28 mice into normal or sublethally irradiated HA28 mice, and as in BALB/c mice, CFSE-labeled LN cells from TS1(SW) mice were also coinjected. In this case, coinjection of TS1(SW) cells, which have a ~100-fold lower affinity for the S1 peptide than 6.5+ cells (8), allowed the specificity of proliferative responses to S1 peptide to be assessed. In contrast to BALB/c mice in which they failed to divide, the 6.5highCD4+CD25+ cells divided up to three times in nonirradiated HA28 mice (Fig. 2A). By contrast, CD4+V{alpha}8+ T cells from TS1(SW) mice did not divide in nonirradiated HA28 mice; this, and the failure of 6.5highCD4+CD25+ T cells to divide in BALB/c mice, indicates that the proliferation of 6.5highCD4+CD25+ T cells in HA28 mice is a specific response to S1 peptide (Fig. 2A).

S1 peptide also induced 6.5highCD4+CD25+ T cells to proliferate in lymphopenic HA28 mice (Fig. 2A). In this case, 6.5highCD4+CD25+ T cells divided approximately four to five times, whereas CD4+V{alpha}8+ T cells went through one to two rounds of division (similar to their division in lymphopenic BALB/c mice). Interestingly, the expansion of 6.5highCD4+CD25+ T cells in lymphopenic HA28 mice was greater than in nonirradiated HA28 mice, suggesting that their proliferative response to S1 peptide may be enhanced by an increase in space provided by lymphopenia. It is possible that IL-7 signals synergize with TCR signals to enhance proliferation of CD4+CD25+ T cells in lymphopenic HA28 mice, despite the low levels of CD127 that are expressed. However, if this is the case, the ability to respond to IL-7 is nevertheless dependent on interactions with S1 peptide, because these cells did not proliferate in response to lymphopenia alone in BALB/c mice. It is also noteworthy that 6.5highCD4+CD25+ T cells did not suppress the homeostatic proliferation of the cotransferred CD4+V{alpha}8+ T cells, as has previously been reported (18, 19). Together with the observations in BALB/c mice, these findings indicate that the peripheral expansion of 6.5highCD4+CD25+ regulatory T cells in HA28 mice is both promoted by and dependent on interactions with the S1 peptide.

We also examined the proliferation of 6.5highCD4+CD25- T cells from TS1 x HA28 mice following transfer into HA28 mice. 6.5highCD4+CD25- T cells proliferated extensively in response to S1 peptide in both nonirradiated and irradiated HA28 mice, in each case going through as many as five divisions (Fig. 2A). Although they express high levels of CD127 and proliferate in lymphopenic BALB/c mice, the ability to respond to IL-7 did not appear to significantly enhance 6.5highCD4+CD25- cell proliferation in lymphopenic vs nonirradiated HA28 mice. The proliferation of CD4+CD25- T cells did not appear to limit the proliferation of the cotransferred CD4+V{alpha}8+ T cells in the time period examined, in contrast with recent studies in another system (20). Importantly, the different proliferative capacities of 6.5highCD4+CD25+ and 6.5highCD4+CD25- T cells in response to S1 peptide in HA28 mice correlated well with the abilities of these cells to respond to S1 peptide in vitro where, in the absence of IL-2, 6.5highCD4+CD25+ T cells divided one to two times, whereas 6.5highCD4+CD25- T cells divided four to five times (Ref.14 and Fig. 2B).

Peripheral expansion does not abrogate regulatory function of CD4+CD25+ T cells

To determine whether they retain regulatory function following proliferation in vivo, CD4+CD25+ cells from TS1 x HA28 mice that had undergone division in response to S1 peptide in HA28 mice were reisolated based on CFSE intensity (Fig. 3A). These cells were then examined for their ability to suppress S1-induced in vitro proliferation of TS1 LN cells. CD4+CD25+ cells that had undergone division in vivo were as potent suppressors of proliferation as undivided cells (Fig. 3B). CD4+CD25+ cells were also as potent suppressors as freshly isolated CD4+CD25+ T cells from TS1 x HA28 mice, whereas freshly isolated CD4+CD25- cells from TS1 x HA28 mice did not suppress proliferation of TS1 LN cells. This indicates that CD4+CD25+ T cells retain their regulatory properties following in vivo proliferation, as previously described (13). These data further show that the regulatory CD4+CD25+ cells themselves (and not some other population of CD4+CD25+ cells) undergo division in response to S1 peptide in HA28 mice.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 3. In vivo proliferation does not abrogate the regulatory function of CD4+CD25+ T cells. A, A total of 1.5–2 x 106 purified CFSE-labeled CD4+CD25+ cells from TS1 x HA28 mice were injected i.v. into sublethally irradiated HA28 mice. Seven days later, transferred CD4+CD25+ cells were harvested from the LN and spleens of recipient mice and purified by cell sorting into an undivided CD4+CFSEhigh population and a divided CD4+CFSEint-low population. B, TS1 LN cells were cultured with graded numbers of cell populations purified in A or with freshly isolated CD4+CD25+ or CD4+CD25- cells from TS1 x HA28 mice and stimulated with 0.3 µM S1 peptide. Proliferation of responder TS1 LN cells was assessed by [3H]thymidine incorporation. Data are representative of two experiments.

 
Conclusions

In TS1 x HA28 mice, the peptide that mediates the thymic selection of 6.5highCD4+CD25+ T cells is known, and we show in this study that this same peptide can induce the expansion of 6.5highCD4+CD25+ T cells in the periphery. Moreover, the peripheral expansion of 6.5highCD4+CD25+ T cells is dependent on interactions with S1 peptide, because unlike conventional CD4+ T cells (and also 6.5highCD4+CD25- T cells from TS1 x HA28 mice), the 6.5highCD4+CD25+ T cells did not proliferate in response to lymphopenia in BALB/c mice. Several studies have previously demonstrated the proliferation of polyclonal CD4+CD25+ T cells upon transfer into lymphopenic hosts, and some have shown that CD4+CD25+ T cells proliferate in response to Ag administered by immunization or expressed as a self-Ag (12, 13, 17, 18, 20, 21). Our data establish that the ability to proliferate in response to selecting self-peptide:MHC complex, rather than cytokine-derived signals, directs the expansion of CD4+CD25+ T cells in the periphery.

The failure of CD4+CD25+ T cells to proliferate in response to lymphopenia likely reflects the down-modulation of CD127, which is an important cytokine in directing division of conventional CD4+ T cells under lymphopenic conditions. In this respect, it is noteworthy that conventional CD4+ T cells also down-modulate CD127 upon activation, and that CD4+CD25+ regulatory T cells exhibit other phenotypic characteristics, such as increased levels of CTLA-4 and glucocorticoid-induced thymocyte receptor, that they share with activated conventional CD4+ T cells (Refs.22, 23, 24, 25, 26 and data not shown). Whether CD4+CD25+ regulatory T cells exhibit characteristics in common with activated CD4+ T cells as a consequence of high-affinity interactions with self-peptides during their selection in the thymus and/or as a result of ongoing interactions with self-peptides in the periphery remains to be determined. Nevertheless, down-modulation of CD127 on CD4+CD25+ regulatory T cells, coupled with the ability to proliferate in response to their selecting peptide, likely significantly affects how CD4+CD25+ regulatory T cells accumulate in the periphery. 6.5highCD4+CD25+ T cells accumulate in large numbers systemically in TS1 x HA28 mice, because S1 peptide is expressed in a wide variety of tissues (data not shown), and CD4+CD25+ regulatory T cells directed toward ubiquitously expressed bona fide self-Ags are likely to be similarly represented in high numbers and to be systemically distributed. In other cases, CD4+CD25+ T cells that are specific for tissue-restricted Ags proliferated and accumulated selectively in LN draining sites of Ag expression (11, 12, 27). Their differing responsiveness to TCR- vs cytokine-mediated signals provides a mechanism by which CD4+CD25+ T cells specific for tissue-restricted self-Ags (and that may undergo thymic selection via promiscuous expression in thymic epithelial cells (28)) can accumulate selectively at sites of Ag expression, even in lymphopenia.


    Acknowledgments
 
We thank Heath M. Guay for assistance; Andrew Rankin, Alina Boesteanu, and Melissa Lerman for thoughtful discussion; J. S. Faust and A. L. Acosta at The Wistar Institute flow cytometry facility for cell sorting; and the University of Pennsylvania flow cytometry facility.


    Footnotes
 
1 This study was supported by grants from the National Institutes of Health, by the Lupus Foundation of Southeastern Pennsylvania, and by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health. Back

2 Address correspondence and reprint requests to Dr. Andrew J. Caton, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. E-mail address: caton{at}wistar.upenn.edu Back

3 Abbreviations used in this paper: LN, lymph node; int, intermediate. Back

Received for publication July 11, 2003. Accepted for publication October 10, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Jameson, S. C.. 2002. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2:547.[Medline]
  2. Goldrath, A. W., M. J. Bevan. 1999. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 11:183.[Medline]
  3. Viret, C., F. S. Wong, C. A. Janeway, Jr. 1999. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10:559.[Medline]
  4. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11:173.[Medline]
  5. Fry, T. J., C. L. Mackall. 2001. Interleukin-7: master regulator of peripheral T-cell homeostasis?. Trends Immunol. 22:564.[Medline]
  6. Seddon, B., R. Zamoyska. 2002. TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J. Immunol. 169:3752.[Abstract/Free Full Text]
  7. Shevach, E. M.. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423.[Medline]
  8. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, A. J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.[Medline]
  9. Apostolou, I., A. Sarukhan, L. Klein, H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:756.[Medline]
  10. Seddon, B., D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:877.[Abstract/Free Full Text]
  11. Fisson, S., G. Darrasse-Jeze, E. Litvinova, F. Septier, D. Klatzmann, R. Liblau, B. L. Salomon. 2003. Continuous activation of autoreactive CD4+CD25+ regulatory T cells in the steady state. J. Exp. Med. 198:737.[Abstract/Free Full Text]
  12. Walker, L. S., A. Chodos, M. Eggena, H. Dooms, A. K. Abbas. 2003. Antigen-dependent proliferation of CD4+CD25+ regulatory T cells in vivo. J. Exp. Med. 198:249.[Abstract/Free Full Text]
  13. Klein, L., K. Khazaie, H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100:8886.[Abstract/Free Full Text]
  14. Jordan, M. S., M. P. Riley, H. von Boehmer, A. J. Caton. 2000. Anergy and suppression regulate CD4+ T cell responses to a self peptide. Eur. J. Immunol. 30:136.[Medline]
  15. Kirberg, J., A. Baron, S. Jakob, A. Rolink, K. Karjalainen, H. von Boehmer. 1994. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180:25.[Abstract/Free Full Text]
  16. Lyons, A. B., C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.[Medline]
  17. Gavin, M. A., S. R. Clarke, E. Negrou, A. Gallegos, A. Rudensky. 2002. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat. Immunol. 3:33.[Medline]
  18. McHugh, R. S., E. M. Shevach. 2002. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:5979.[Abstract/Free Full Text]
  19. Prlic, M., B. R. Blazar, A. Khoruts, T. Zell, S. C. Jameson. 2001. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 167:5664.[Abstract/Free Full Text]
  20. Barthlott, T., G. Kassiotis, B. Stockinger. 2003. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197:451.[Abstract/Free Full Text]
  21. Annacker, O., R. Pimenta-Araujo, O. Burlen-Defranoux, T. C. Barbosa, A. Cumano, A. Bandeira. 2001. CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008.[Abstract/Free Full Text]
  22. Schluns, K. S., W. C. Kieper, S. C. Jameson, L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426.[Medline]
  23. Xue, H. H., P. E. Kovanen, C. A. Pise-Masison, M. Berg, M. F. Radovich, J. N. Brady, W. J. Leonard. 2002. IL-2 negatively regulates IL-7 receptor {alpha} chain expression in activated T lymphocytes. Proc. Natl. Acad. Sci. USA 99:13759.[Abstract/Free Full Text]
  24. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, S. Sakaguchi. 2002. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135.[Medline]
  25. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T. W. Mak, S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.[Abstract/Free Full Text]
  26. Read, S., V. Malmstrom, F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.[Abstract/Free Full Text]
  27. Green, E. A., Y. Choi, R. A. Flavell. 2002. Pancreatic lymph node-derived CD4+CD25+ Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183.[Medline]
  28. Derbinski, J., A. Schulte, B. Kyewski, L. Klein. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2:1032.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
A. L. Tang, J. R. Teijaro, M. N. Njau, S. S. Chandran, A. Azimzadeh, S. G. Nadler, D. M. Rothstein, and D. L. Farber
CTLA4 Expression Is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis
J. Immunol., August 1, 2008; 181(3): 1806 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh
IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia
J. Immunol., June 1, 2008; 180(11): 7265 - 7275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Fernandez, F. K. Puttur, Y. M. Wang, W. Howden, S. I. Alexander, and C. A. Jones
T Regulatory Cells Contribute to the Attenuated Primary CD8+ and CD4+ T Cell Responses to Herpes Simplex Virus Type 2 in Neonatal Mice
J. Immunol., February 1, 2008; 180(3): 1556 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Siewert, U. Lauer, S. Cording, T. Bopp, E. Schmitt, A. Hamann, and J. Huehn
Experience-Driven Development: Effector/Memory-Like {alpha}E+Foxp3+ Regulatory T Cells Originate from Both Naive T Cells and Naturally Occurring Naive-Like Regulatory T Cells
J. Immunol., January 1, 2008; 180(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Chappert, M. Leboeuf, P. Rameau, D. Stockholm, R. Liblau, O. Danos, J. M. Davoust, and D.-A. Gross
Antigen-Driven Interactions with Dendritic Cells and Expansion of Foxp3+ Regulatory T Cells Occur in the Absence of Inflammatory Signals
J. Immunol., January 1, 2008; 180(1): 327 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Li, N. Perez, S. Karumuthil-Melethil, B. S. Prabhakar, M. J. Holterman, and C. Vasu
Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25 TGF-beta1+ Adaptive Regulatory T Cells
J. Immunol., October 15, 2007; 179(8): 5191 - 5203.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hao, Y. Liu, J. Yuan, X. Zhang, T. He, X. Wu, Y. Wei, D. Sun, and J. Xiang
Novel Exosome-Targeted CD4+ T Cell Vaccine Counteracting CD4+25+ Regulatory T Cell-Mediated Immune Suppression and Stimulating Efficient Central Memory CD8+ CTL Responses
J. Immunol., September 1, 2007; 179(5): 2731 - 2740.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Kapp, K. Honjo, L. M. Kapp, K. Goldsmith, and R. P. Bucy
Antigen, in the Presence of TGF-beta, Induces Up-Regulation of FoxP3gfp+ in CD4+ TCR Transgenic T Cells That Mediate Linked Suppression of CD8+ T Cell Responses
J. Immunol., August 15, 2007; 179(4): 2105 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Codarri, L. Vallotton, D. Ciuffreda, J.-P. Venetz, M. Garcia, K. Hadaya, L. Buhler, S. Rotman, M. Pascual, and G. Pantaleo
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7R{alpha}high cell population in solid organ transplant recipients
J. Exp. Med., July 9, 2007; 204(7): 1533 - 1541.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. L. Stephens, J. Andersson, and E. M. Shevach
Distinct Subsets of FoxP3+ Regulatory T Cells Participate in the Control of Immune Responses
J. Immunol., June 1, 2007; 178(11): 6901 - 6911.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Bayer, A. Yu, and T. R. Malek
Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T Regulatory Cells
J. Immunol., April 1, 2007; 178(7): 4062 - 4071.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Steptoe, J. M. Ritchie, N. S. Wilson, J. A. Villadangos, A. M. Lew, and L. C. Harrison
Cognate CD4+ Help Elicited by Resting Dendritic Cells Does Not Impair the Induction of Peripheral Tolerance in CD8+ T Cells
J. Immunol., February 15, 2007; 178(4): 2094 - 2103.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Tellier, J. P. M. van Meerwijk, and P. Romagnoli
An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes
Int. Immunol., November 1, 2006; 18(11): 1509 - 1519.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yu and T. R. Malek
Selective Availability of IL-2 Is a Major Determinant Controlling the Production of CD4+CD25+Foxp3+ T Regulatory Cells
J. Immunol., October 15, 2006; 177(8): 5115 - 5121.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Bourgeois and B. Stockinger
CD25+CD4+ Regulatory T Cells and Memory T Cells Prevent Lymphopenia-Induced Proliferation of Naive T Cells in Transient States of Lymphopenia
J. Immunol., October 1, 2006; 177(7): 4558 - 4566.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Ford, Z.-X. Zhang, W. Chen, and L. Zhang
Double-Negative T Regulatory Cells Can Develop Outside the Thymus and Do Not Mature from CD8+ T Cell Precursors.
J. Immunol., September 1, 2006; 177(5): 2803 - 2809.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Rezvani, S. Mielke, M. Ahmadzadeh, Y. Kilical, B. N. Savani, J. Zeilah, K. Keyvanfar, A. Montero, N. Hensel, R. Kurlander, et al.
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Blood, August 15, 2006; 108(4): 1291 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al.
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
J. Exp. Med., July 10, 2006; 203(7): 1693 - 1700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Baecher-Allan, E. Wolf, and D. A. Hafler
MHC class II expression identifies functionally distinct human regulatory T cells.
J. Immunol., April 15, 2006; 176(8): 4622 - 4631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani
Regulatory T Cells Are Expanded in Blood and Disease Sites in Patients with Tuberculosis
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 803 - 810.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. de Kleer, B. Vastert, M. Klein, G. Teklenburg, G. Arkesteijn, G. P. Yung, S. Albani, W. Kuis, N. Wulffraat, and B. Prakken
Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network
Blood, February 15, 2006; 107(4): 1696 - 1702.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Y. Setiady, K. Ohno, E. T. Samy, H. Bagavant, H. Qiao, C. Sharp, J. X. She, and K. S. K. Tung
Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+CD25+ regulatory T cells
Blood, February 1, 2006; 107(3): 1056 - 1062.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, J. R. Kalden, P. E. Lipsky, and H. Schulze-Koops
The IL-4 Receptor {alpha}-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25-CD4+ Precursors
J. Immunol., November 1, 2005; 175(9): 6107 - 6116.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
E. T. Samy, L. A. Parker, C. P. Sharp, and K. S.K. Tung
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node
J. Exp. Med., September 19, 2005; 202(6): 771 - 781.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Lundsgaard, T. L. Holm, L. Hornum, and H. Markholst
In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells Expressing Foxp3
Diabetes, April 1, 2005; 54(4): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Schenk, D. D. Kish, C. He, T. El-Sawy, E. Chiffoleau, C. Chen, Z. Wu, S. Sandner, A. V. Gorbachev, K. Fukamachi, et al.
Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells
J. Immunol., March 15, 2005; 174(6): 3741 - 3748.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. L. Bayer, A. Yu, D. Adeegbe, and T. R. Malek
Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period
J. Exp. Med., March 7, 2005; 201(5): 769 - 777.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Antony, C. A. Piccirillo, A. Akpinarli, S. E. Finkelstein, P. J. Speiss, D. R. Surman, D. C. Palmer, C.-C. Chan, C. A. Klebanoff, W. W. Overwijk, et al.
CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells
J. Immunol., March 1, 2005; 174(5): 2591 - 2601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Y. Wang, G. Peng, Z. Guo, E. M. Shevach, and R.-F. Wang
Recognition of a New ARTC1 Peptide Ligand Uniquely Expressed in Tumor Cells by Antigen-Specific CD4+ Regulatory T Cells
J. Immunol., March 1, 2005; 174(5): 2661 - 2670.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Hanash and R. B. Levy
Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation
Blood, February 15, 2005; 105(4): 1828 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. J. Turk, J. A. Guevara-Patino, G. A. Rizzuto, M. E. Engelhorn, and A. N. Houghton
Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells
J. Exp. Med., September 20, 2004; 200(6): 771 - 782.
[Abstract] [Full Text] [PDF]